X
J&J gets quick approval for new next-gen prostate cancer drug
https://pharmaphorum.com/news/jj-gets-quick-approval-new-next-gen-prostate-cancer-drug/
Prostate cancer
US court invalidates key patent on J&J’s Zytiga
J&J to appeal decision.
EU regulators back J&J’s Zytiga in early prostate cancer use
New use could give J&J drug edge over Pfizer’s rival
Pfizer confirms $14bn Medivation merger
Drug giant confirms press reports.
Robots don’t improve prostate surgery outcomes, says study
No differences found in urinary function, post-operative complications or days off work.
NICE lifts restrictions on Ferring prostate cancer drug
Decision followed a successful appeal by manufacturer.
Pharma gets social: did digital opinion leaders shape NICE guidance on Xtandi?
Digital Opinion Leaders as activists in healthcare decision making.